New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...

A day after getting exposed to the Ebola virus, ten monkeys then received an Obeldesivir pill daily for ten days, while three control monkeys received no treatment and died. The study found that ...

Similar to the more widely known Ebola hemorrhagic fever, MHF is characterized by systemic viral replication, immunosuppression and abnormal inflammatory responses. These pathological features of ...

The World Health Organisation (WHO) has ruled out the mystery disease being Ebola or Marburg, but say those infected are presenting symptoms of a "hemorrhagic fever". The DRC, in particular ...

More than 50 people have died in the Democratic Republic of the Congo, most within 48 hours of the onset of symptoms. Initial analysis suggests neither Ebola nor Marburg is the cause.

Ebola, which is spread by contact with the bodily fluids of an infected person or contaminated materials, manifests as a ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

The DOGE team shows no understanding of how much work and human expertise go into protecting Americans from infectious ...

Ebola, which is spread by contact with the bodily fluids of an infected person or contaminated materials, manifests as a deadly hemorrhagic fever. Symptoms include fever, vomiting, diarrhea ...